Literature DB >> 23941696

Identification of a specific one amino acid change in recombinant human transglutaminase 2 that regulates its activity and calcium sensitivity.

Kajal Kanchan1, Elvan Ergülen, Robert Király, Zsófia Simon-Vecsei, Mónika Fuxreiter, László Fésüs.   

Abstract

TG2 (transglutaminase 2) is a calcium-dependent protein cross-linking enzyme which is involved in a variety of cellular processes. The threshold level of calcium needed for endogenous and recombinant TG2 activity has been controversial, the former being more sensitive to calcium than the latter. In the present study we address this question by identifying a single amino acid change from conserved valine to glycine at position 224 in recombinant TG2 compared with the endogenous sequence present in the available genomic databases. Substituting a valine residue for Gly224 in the recombinant TG2 increased its calcium-binding affinity and transamidation activity 10-fold and isopeptidase activity severalfold, explaining the inactivity of widely used recombinant TG2 at physiological calcium concentrations. ITC (isothermal titration calorimetry) measurements showed 7-fold higher calcium-binding affinities for TG2 valine residues which could be activated inside cells. The two forms had comparable substrate- and GTP-binding affinities and also bound fibronectin similarly, but coeliac antibodies had a higher affinity for TG2 valine residues. Structural analysis indicated a higher stability for TG2 valine residues and a decrease in flexibility of the calcium-binding loop resulting in improved metal-binding affinity. The results of the present study suggest that Val224 increases TG2 activity by modulating its calcium-binding affinity enabling transamidation reactions inside cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23941696     DOI: 10.1042/BJ20130696

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  An unprecedented dual antagonist and agonist of human Transglutaminase 2.

Authors:  Michael C Yi; Brad A Palanski; Steven A Quintero; Nicholas M Plugis; Chaitan Khosla
Journal:  Bioorg Med Chem Lett       Date:  2015-05-15       Impact factor: 2.823

2.  Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2.

Authors:  Cornelius Klöck; Zachary Herrera; Megan Albertelli; Chaitan Khosla
Journal:  J Med Chem       Date:  2014-10-31       Impact factor: 7.446

Review 3.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

4.  Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.

Authors:  Kathrin Hnida; Jorunn Stamnaes; M Fleur du Pré; Simon Mysling; Thomas J D Jørgensen; Ludvig M Sollid; Rasmus Iversen
Journal:  J Biol Chem       Date:  2016-10-26       Impact factor: 5.157

5.  Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2.

Authors:  Kiruphagaran Thangaraju; Róbert Király; Máté A Demény; János András Mótyán; Mónika Fuxreiter; László Fésüs
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

6.  Structure of natural variant transglutaminase 2 reveals molecular basis of gaining stability and higher activity.

Authors:  Hyun Ji Ha; Sunghark Kwon; Eui Man Jeong; Chang Min Kim; Ki Baek Lee; In-Gyu Kim; Hyun Ho Park
Journal:  PLoS One       Date:  2018-10-15       Impact factor: 3.240

7.  Outcome measures in coeliac disease trials: the Tampere recommendations.

Authors:  Jonas F Ludvigsson; Carolina Ciacci; Peter Hr Green; Katri Kaukinen; Ilma R Korponay-Szabo; Kalle Kurppa; Joseph A Murray; Knut Erik Aslaksen Lundin; Markku J Maki; Alina Popp; Norelle R Reilly; Alfonso Rodriguez-Herrera; David S Sanders; Detlef Schuppan; Sarah Sleet; Juha Taavela; Kristin Voorhees; Marjorie M Walker; Daniel A Leffler
Journal:  Gut       Date:  2018-02-13       Impact factor: 23.059

8.  Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction.

Authors:  Ádám Diós; Rita Elek; Ildikó Szabó; Szilvia Horváth; Judit Gyimesi; Róbert Király; Katharina Werkstetter; Sibylle Koletzko; László Fésüs; Ilma R Korponay-Szabó
Journal:  Amino Acids       Date:  2021-05-31       Impact factor: 3.520

9.  Transglutaminase 2 mediates UV-induced skin inflammation by enhancing inflammatory cytokine production.

Authors:  Seok-Jin Lee; Ki Baek Lee; Young Hoon Son; Jiwoong Shin; Jin-Haeng Lee; Hyo-Jun Kim; Ah-Young Hong; Hee Won Bae; Mee-Ae Kwon; Won Jong Lee; Jin-Hee Kim; Dong Hun Lee; Eui Man Jeong; In-Gyu Kim
Journal:  Cell Death Dis       Date:  2017-10-26       Impact factor: 8.469

10.  Structure functional insights into calcium binding during the activation of coagulation factor XIII A.

Authors:  Sneha Singh; Johannes Dodt; Peter Volkers; Emma Hethershaw; Helen Philippou; Vytautus Ivaskevicius; Diana Imhof; Johannes Oldenburg; Arijit Biswas
Journal:  Sci Rep       Date:  2019-08-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.